Cargando…
Oligomeric protein interference validates druggability of aspartate interconversion in Plasmodium falciparum
The appearance of multi‐drug resistant strains of malaria poses a major challenge to human health and validated drug targets are urgently required. To define a protein's function in vivo and thereby validate it as a drug target, highly specific tools are required that modify protein function wi...
Autores principales: | Batista, Fernando A., Bosch, Soraya S., Butzloff, Sabine, Lunev, Sergey, Meissner, Kamila A., Linzke, Marleen, Romero, Atilio R., Wang, Chao, Müller, Ingrid B., Dömling, Alexander S. S., Groves, Matthew R., Wrenger, Carsten |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6612543/ https://www.ncbi.nlm.nih.gov/pubmed/30821109 http://dx.doi.org/10.1002/mbo3.779 |
Ejemplares similares
-
Oligomeric interfaces as a tool in drug discovery: Specific interference with activity of malate dehydrogenase of Plasmodium falciparum in vitro
por: Lunev, Sergey, et al.
Publicado: (2018) -
Trafficked Proteins—Druggable in Plasmodium falciparum?
por: Lindner, Jasmin, et al.
Publicado: (2013) -
Vitamin B6-Dependent Enzymes in the Human Malaria Parasite Plasmodium falciparum: A Druggable Target?
por: Kronenberger, Thales, et al.
Publicado: (2014) -
Novel Highlight in Malarial Drug Discovery: Aspartate Transcarbamoylase
por: Wang, Chao, et al.
Publicado: (2022) -
A fragment-based approach identifies an allosteric pocket that impacts malate dehydrogenase activity
por: Reyes Romero, Atilio, et al.
Publicado: (2021)